Somatostatin is one kind of hormone. It is widely distributed throughout the body, especially in the hypothalamus and pancreas. It also acts as an important regulator of endocrine and nervous system function by inhibiting the secretion of several other hormones such as growth hormone, insulin, and gastrin.
This report contains market size and forecasts of Somatostatin in global, including the following market information:
Global Somatostatin Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Somatostatin Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Somatostatin companies in 2021 (%)
The global Somatostatin market was valued at 346.3 million in 2021 and is projected to reach US$ 715 million by 2028, at a CAGR of 10.9% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
0.25mg/pcs Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Somatostatin include Merck (Schweiz) AG, SANOFI-AVENTIS FRANCE, Lyomark Pharma GmbH, ALFA WASSERMANN S.p.A., Polypeptide Laboratories, Inc, SAMARTH, UBPL, HYBIO and TianTaiShan, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Somatostatin manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Somatostatin Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Somatostatin Market Segment Percentages, by Type, 2021 (%)
0.25mg/pcs
0.75mg/pcs
3mg/pcs
Global Somatostatin Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Somatostatin Market Segment Percentages, by Application, 2021 (%)
Hormonal Disorder
Oncology
Metabolic Disorder
Others
Global Somatostatin Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Somatostatin Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Somatostatin revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Somatostatin revenues share in global market, 2021 (%)
Key companies Somatostatin sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Somatostatin sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck (Schweiz) AG
SANOFI-AVENTIS FRANCE
Lyomark Pharma GmbH
ALFA WASSERMANN S.p.A.
Polypeptide Laboratories, Inc
SAMARTH
UBPL
HYBIO
TianTaiShan
Yangtze River
Siyao
Shuangcheng
Hainan Zhonghe
SL PHARM
Wuhan Hualong
Qingdao Guoda
Chengdu Shengnuo
Longjin